Dahua Technology Unveils Full-color Cube to Explore New Possibilities of Innovation
19.4.2023 15:45:00 EEST | Business Wire | Press release
Dahua Technology, a world-leading video-centric AIoT solution and service provider, unveils the 2023 Full-color Cube concept —— a cube of color magic that combines Full-color, Smart Dual Light and other technologies into infinite possibilities of innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230419005078/en/
For years, Dahua has been investing in Full-color Technology that assures users 24/7 colorful monitoring as well as trust-worthy performance in terms of clarity, definition, flexibility, accuracy and intelligence. This year, meet Full-color Cube! It integrates Full-color and Smart Dual Light with other technologies, creating infinite possibilities for innovation and allowing you to do more than you could ever imagine. (Photo: Business Wire)
“Dahua’s Full-color technology is continuously being upgraded, with the addition of Smart Dual Light as one great example. This year, we combined these two core technologies with AI, Duo and PT cameras, as well as other technologies to offer the Full-color Cube that further addresses users’ monitoring needs for vivid and color images in low-light environments,” said Eaden Xie, Product Manager at Dahua Technology.
Featuring panoramic vision, more personalized and flexible settings, intelligence at will, and future growth, the Full-color Cube unlocks a wealth of cutting-edge security functions through strong technological combinations.
Full-color + Panoramic: seamless 180° wide-angle image
The Full-color Panoramic series achieves a wider range of vision coverage by utilizing the capabilities of both Full-color Duo and PT cameras.
- Full-color + Duo
Based on Dahua’s advanced pixel-level metadata fusion algorithm, Full-color Duo camera adopts Dual F1.0 Aperture Lens and Dual 1/1.8" CMOS Sensors to create better imaging effects in low-light conditions. Compared with traditional cameras, its seamless 180° image significantly saves equipment and installation costs. Also, the eyeball model supports 3-axis rotation, which makes installation and operation more convenient. Moreover, its EPTZ function features panoramic image with multiple target details.
- Full-color + PT
Equipped with larger pan & tilt angle, Full-color PT camera provides an expanded field of view with fewer blind spots, while capturing 24/7 color images for more information and details. A variety of mounting brackets makes it easy to install on a pole, ceiling, or wall.
TiOC: full-time protection before, during, and after an event
TiOC (Three-in-One Camera) is a star product of the Dahua Full-color family that integrates Smart Dual Light, Active Deterrence, and AI. Before the event, SMD 4.0 and Perimeter Protection technology accurately focuses on human and vehicle alarms. During the event, Smart Dual Light technology records events in color, while actively deterring intruders with red and blue lights and siren. After the event, Smart Search quickly retrieves target footages, reducing investigation time. TiOC also allows third-party platform access for live broadcast/playback, video and audio parameter configuration, etc.
For more details about Full-color Cubes, please visit here .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230419005078/en/
Contact information
Zoe Xu (xu_shuyi@dahuatech.com )
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom